老挝全球药房Laos Global Pharmacy
Carrying forward a five-thousand-year legacy, safeguarding modern health
兰泽替尼是第三代口服不可逆EGFR‑TKI,精准抑制EGFR敏感/耐药突变、脑转移控制佳、毒性低,与埃万妥单抗联用为EGFR 经典突变晚期NSCLC一线高效方案。
所有称呼兰泽替尼、Lazertinib、LuciLazer、Leclaza
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
Order on WhatsApp